Search results for: 'fare digitization'

By 2027, 82.2% of major mobile operators in Asia-Pacific (APAC) will remain as telcos, with 25% likely to exit or become MVNOs. Only 17.8% of major mobile operators in APAC will become Techcos (technology companies). Being passive and dependent on vendors for innovation has made the industry weak in driving innovation, leveraging technology, and th...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...

Over the course of the projection period, the market for CX management is expected to expand. This is mostly due to two factors: 1) the growing recognition of CX as a potent tool for competitive advantage, and 2) the increasing motivation for businesses to outsource their CX activities. This market is poised for disruption due to the emergence o...

Software-defined automation (SDA) represents a paradigm shift in industrial and manufacturing control systems that addresses traditional operational technology (OT) architectures' limitations. As proprietary, hardware-intensive automation systems reach the end of their life cycles, they increasingly hinder innovation, scalability, and adaptability ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...

The Advanced Manufacturing Technology Opportunity Engine provides profiles of innovations related to autonomous mobile robots (AMRs) enabling pallet and trolley transportation across dynamic intralogistics environments; compact 6-axis robotic systems supporting modular and flexible laboratory automation; autonomous agricultural unmanned ground vehi...

This study on industrial pump services provides an in-depth analysis of the key trends impacting OEM revenues and forecasts industry growth until 2030. It discusses market revenue by end user and the various services offered by leading pump vendors. It also provides a region-wise analysis of various services and related forecasts. Industrial pump s...